Genalyte

About:

Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.

Website: http://www.genalyte.com

Twitter/X: genalyte

Top Investors: Khosla Ventures, Verily, Samsara BioCapital, Redmile Group, HBM Partners

Description:

Genalyte, Inc. is a life sciences company developing and commercializing innovative next-generation multiplexing technology. Genalyte has developed a new approach to immunodetection using silicon chip manufacturing methods. Its Maverick platform uses a technology called silicon photonics to directly measure protein binding between antibodies and antigens or hybridization of nucleic acids.

Total Funding Amount:

$155M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2007-01-01

Contact Email:

sales(AT)genalyte.com

Founders:

Cary Gunn

Number of Employees:

51-100

Last Funding Date:

2023-03-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai